Cite
HARVARD Citation
Kruppert, S. et al. (n.d.). S1041 Treatment Patterns of an Adalimumab Biosimilar (ABP 501) Among Patients With Inflammatory Bowel Disease: An Observational Study Using German Pharmacy Claims Database. American journal of gastroenterology. pp. e754-e755. [Online].